http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999296-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43509 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-80 |
filingDate | 2021-11-04^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-11-01^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-11-01^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113999296-B |
titleOfInvention | A novel antibacterial polypeptide Spgillcin177-189 of Scylla simulans and its application |
abstract | The invention discloses a new type of antibacterial polypeptide Spgillcin 177-189 of Scylla simulans and its application. Its molecular formula is C 80 H 126 N 26 O 15 S 1 , and its amino acid sequence is shown in SEQ ID NO: 01. The novel antibacterial polypeptide Spgillcin 177-189 of the present invention has significant antibacterial effect on common pathogenic bacteria, and in addition, it has no cells on normal Scylla simulans blood cells, normal mammalian cells such as mouse liver parenchyma cells and normal human liver cells. Toxicity, which originates from crustaceans, can be used in aquafeed additives and antibacterial drugs, etc., and has broad application prospects. |
priorityDate | 2021-11-04^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 61 of 61.